Abeona Therapeutics Inc. · NASDAQ:ABEO
Montanova Capital, LLC reported a 5.20% stake in Abeona Therapeutics Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 13, 2025
Montanova Capital, LLC reported a 5.20% stake in Abeona Therapeutics Inc., 2,676,000 shares, as a passive investor on Jun 30, 2025. Filed Aug 13, 2025 (Schedule 13G/A).
- Stake
- 5.20%
- Shares
- 2,676,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Suvretta Capital Management, LLC | 5.20% | 2,676,000 |
| Averill Master Fund, Ltd. | 4.50% | 2,309,267 |
| Aaron Cowen | 5.20% | 2,676,000 |
Source
Related
- Abeona Therapeutics Inc.
- Montanova Capital, LLC
- Abeona Therapeutics Inc. shareholders
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Form 4 · Seshadri Vishwas · Sep 29, 2026
- Form 4 · Vazzano Joseph Walter · Sep 29, 2026
- Form 4 · O'Malley Brendan M. · Sep 29, 2026
- Form 4 · Vasanthavada Madhav · Sep 29, 2026
- Form 4 · Alvino Mark · Sep 1, 2026